Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance

Journal: Chemical Science

Published: 2018-04-24

DOI: 10.1039/c8sc00428e

Affiliations: 2

Authors: 5

Go to article
Institutions FC
Institute for Drug Research (IDR), HUJI, Israel 0.60
Department of Pharmaceutical and Pharmacological Sciences (DSF), UNIPD, Italy 0.40

Return